News
Pfizer Inc. raised its profit forecast for the year, with the drugmaker’s ongoing cost cuts helping to make up for a lack of ...
Free Malaysia Today on MSN14h
Pfizer’s earnings boosted by Covid-19 products, lower expensesPfizer was among the 17 companies that received a July 31 letter from president Donald Trump demanding lower drug prices.
Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.
The controversial move affects development of vaccines against COVID-19, flu and H5N1, drawing criticism from public health ...
Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...
Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...
In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...
Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...
MedPage Today on MSN1d
Did FDA Pick the Wrong COVID Vaccine Strain Last Season?The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback